Moelis Australia Asset Management

Total investments

18

Average round size

21M

Portfolio companies

17

Rounds per year

1.29

Lead investments

6

Follow on index

0.06

Exits

3

Stages of investment
Private EquityLate Stage Venture
Areas of investment
E-CommerceSoftwareFinancial ServicesFinTechInformation TechnologyEnterprise SoftwareBig DataBusiness DevelopmentTransaction ProcessingAdvertising Platforms

Summary

In 2009 was created Moelis Australia Asset Management, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Sydney. The venture was found in Australia.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Moelis Australia Asset Management, startups are often financed by Carthona Capital, Yellow Brick Capital Advisers, Singapore Press Holdings. The meaningful sponsors for the fund in investment in the same round are Square Peg Capital, Uniseed Ventures, Time Inc.. In the next rounds fund is usually obtained by Tempus Partners, Roger Allen, Regal Funds Management.

The typical startup value when the investment from Moelis Australia Asset Management is 100-500 millions dollars. Opposing the other organizations, this Moelis Australia Asset Management works on 0 percentage points less the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2018. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity.

Among the most successful fund investment fields, there are Data Integration, Education. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Sparesbox, Ansarada, Clinical Genomics Technologies The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Australia.

Show more

Investments analytics

Analytics

Total investments
18
Lead investments
6
Exits
3
Rounds per year
1.29
Follow on index
0.06
Investments by industry
  • Information Technology (5)
  • Software (4)
  • E-Commerce (4)
  • FinTech (4)
  • Financial Services (3)
  • Show 42 more
Investments by region
  • Australia (14)
  • United States (3)
  • Singapore (1)
Peak activity year
2021
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
10
Avg. valuation at time of investment
144M
Group Appearance index
0.56
Avg. company exit year
10
Avg. multiplicator
0.41
Strategy success index
0.30

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Clinical Genomics Technologies 01 Jun 2018 Biotechnology, Health Care, Health Diagnostics, Genetics Early Stage Venture New South Wales, Sydney, Australia

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.